国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Drosophila melanogaster Apoptosis inhibitor 5 homolog (Aac11), partial CSB-YP896043DLU
CSB-EP896043DLU
CSB-BP896043DLU
CSB-MP896043DLU
CSB-EP896043DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Histone chaperone asf1 (asf1) CSB-YP896044DLU
CSB-EP896044DLU
CSB-BP896044DLU
CSB-MP896044DLU
CSB-EP896044DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Cytochrome P450 9b1 (Cyp9b1), partial CSB-YP896045DLU
CSB-EP896045DLU
CSB-BP896045DLU
CSB-MP896045DLU
CSB-EP896045DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster COP9 signalosome complex subunit 7 (CSN7) CSB-YP896046DLU
CSB-EP896046DLU
CSB-BP896046DLU
CSB-MP896046DLU
CSB-EP896046DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Cytochrome P450 4p1 (Cyp4p1), partial CSB-YP896047DLU
CSB-EP896047DLU
CSB-BP896047DLU
CSB-MP896047DLU
CSB-EP896047DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Protein preli-like (prel) CSB-YP896048DLU
CSB-EP896048DLU
CSB-BP896048DLU
CSB-MP896048DLU
CSB-EP896048DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster H/ACA ribonucleoprotein complex subunit 3 (CG7637) CSB-YP896049DLU
CSB-EP896049DLU
CSB-BP896049DLU
CSB-MP896049DLU
CSB-EP896049DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Protein cutoff (cuff) CSB-YP896050DLU
CSB-EP896050DLU
CSB-BP896050DLU
CSB-MP896050DLU
CSB-EP896050DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Probable cytochrome P450 301a1, mitochondrial (Cyp301a1), partial CSB-YP896051DLU
CSB-EP896051DLU
CSB-BP896051DLU
CSB-MP896051DLU
CSB-EP896051DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster NEDD8-activating enzyme E1 catalytic subunit (CG13343) CSB-YP896052DLU
CSB-EP896052DLU
CSB-BP896052DLU
CSB-MP896052DLU
CSB-EP896052DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Probable cytochrome P450 6a21 (Cyp6a21), partial CSB-YP896053DLU
CSB-EP896053DLU
CSB-BP896053DLU
CSB-MP896053DLU
CSB-EP896053DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster SH3 domain-binding protein 5 homolog (pcs) CSB-YP896054DLU
CSB-EP896054DLU
CSB-BP896054DLU
CSB-MP896054DLU
CSB-EP896054DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Transmembrane protein 131 homolog (CG8370), partial CSB-YP896055DLU
CSB-EP896055DLU
CSB-BP896055DLU
CSB-MP896055DLU
CSB-EP896055DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster S-methyl-5'-thioadenosine phosphorylase (CG4802) CSB-YP896056DLU
CSB-EP896056DLU
CSB-BP896056DLU
CSB-MP896056DLU
CSB-EP896056DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster UPF0279 protein CG14505 (CG14505) CSB-YP896057DLU
CSB-EP896057DLU
CSB-BP896057DLU
CSB-MP896057DLU
CSB-EP896057DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Exocyst complex component 3 (sec6), partial CSB-YP896058DLU
CSB-EP896058DLU
CSB-BP896058DLU
CSB-MP896058DLU
CSB-EP896058DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster General odorant-binding protein 56h (Obp56h) CSB-YP896059DLU
CSB-EP896059DLU
CSB-BP896059DLU
CSB-MP896059DLU
CSB-EP896059DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Tyrosine-protein kinase Src42A (Src42A), partial CSB-YP896060DLU
CSB-EP896060DLU
CSB-BP896060DLU
CSB-MP896060DLU
CSB-EP896060DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Methylthioribose-1-phosphate isomerase (CG11334) CSB-YP896061DLU
CSB-EP896061DLU
CSB-BP896061DLU
CSB-MP896061DLU
CSB-EP896061DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Calcium-binding mitochondrial carrier protein Aralar1 (aralar1), partial CSB-YP896062DLU1
CSB-EP896062DLU1
CSB-BP896062DLU1
CSB-MP896062DLU1
CSB-EP896062DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>